Brief: BioCryst Announces Partnership With Torii Pharmaceutical to Commercialize BCX7353 in Japan for the Prevention of HAE Attacks

Torii Pharmaceutical Co

05/11/2019 06:27

Nov 5 (Reuters) - BioCryst Pharmaceuticals Inc  BCRX.O :
    * BIOCRYST ANNOUNCES PARTNERSHIP WITH TORII PHARMACEUTICAL
TO
COMMERCIALIZE BCX7353 IN JAPAN FOR THE PREVENTION OF HAE ATTACKS
    * BIOCRYST PHARMACEUTICALS- WILL RECEIVE $22 MILLION UPFRONT
PAYMENT AND IS ELIGIBLE TO RECEIVE UP TO AN ADDITIONAL $20
MILLION UPON ACHIEVEMENT OF CERTAIN MILESTONES
    * BIOCRYST PHARMACEUTICALS - BIOCRYST WILL RECEIVE TIERED
ROYALTIES RANGING FROM MID-TEENS TO POTENTIALLY 40 PERCENT OF
JAPANESE NET SALES OF BCX7353

Source text for Eikon:  ID:nGNXTnDHF 
Further company coverage:  BCRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))